Management of Sarcoidosis: When to Treat, How to Treat and for How Long?

Journal article

Abstract Purpose of Review This review draws together recent publications, consensus statements on sarcoidosis and our 25-year collective experience in managing this disease. We focus on pulmonary sarcoidosis, highlighting recent and established concepts in disease mechanisms, the diversity of the clinical course, including possible ‘subtypes’ of sarcoidosis, and how to measure disease activity. We discuss the principles guiding therapeutic intervention and summarise the more recent clinical trials in sarcoidosis. Recent Findings These include recent progress in understanding the mechanisms of disease using new scientific tools, measurements of disease activity using CT and MRI scans, and the potential role of anti-fibrotic treatment for patients with progressive fibrotic sarcoidosis. Summary Sarcoidosis is a heterogeneous disease with variable organ involvement, disease course, and response to treatment. We offer an angle on when and how to treat, and provide an overall roadmap for managing sarcoidosis.

Authors: Fraser, E; Weeratunga, P; Ho, L-P

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Springer
• Journal: Current Pulmonology Reports
• Volume: 11
• Issue: 4
• Pages: 151-159
• Publication date: 2022-11-29
• DOI: 10.1007/s13665-022-00298-2
• EISSN: 2199-2428
• ISSN: 2199-2428
• Language: English
• Keywords: Disease; Sarcoidosis; Intervention (counseling); Psychiatry; Granulomatous disease; Medicine; Clinical trial; Pathology; Intensive care medicine; Systemic disease